GCL Global shifts listing to Nasdaq Capital Market on Sept. 18 amid bid-price deficiency cure period

PUBT · 1d ago
GCL Global shifts listing to Nasdaq Capital Market on Sept. 18 amid bid-price deficiency cure period
  • GCL Global Holdings will shift its Nasdaq listing to the Nasdaq Capital Market at the open on Sept. 18, 2026.
  • Ordinary shares will keep trading under GCL; warrants will remain listed under GCLWW.
  • Nasdaq granted an extra 180 days to regain compliance with the minimum bid price requirement, extending the deadline to March 15, 2027.
  • Transfer is expected to proceed without trading disruption.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GCL Global Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-100748), on September 17, 2026, and is solely responsible for the information contained therein.